A detailed history of Fifth Third Bancorp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 14,529 shares of CRL stock, worth $2.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,529
Previous 14,741 1.44%
Holding current value
$2.75 Million
Previous $3.05 Million 6.01%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$187.96 - $245.29 $39,847 - $52,001
-212 Reduced 1.44%
14,529 $2.86 Million
Q2 2024

Jul 22, 2024

BUY
$206.39 - $268.73 $424,131 - $552,240
2,055 Added 16.2%
14,741 $3.05 Million
Q1 2024

Apr 23, 2024

BUY
$203.52 - $273.43 $126,996 - $170,620
624 Added 5.17%
12,686 $3.44 Million
Q4 2023

Jan 19, 2024

BUY
$164.52 - $238.84 $95,421 - $138,527
580 Added 5.05%
12,062 $2.85 Million
Q3 2023

Oct 31, 2023

SELL
$194.44 - $217.61 $4,277 - $4,787
-22 Reduced 0.19%
11,482 $2.25 Million
Q2 2023

Jul 25, 2023

BUY
$183.71 - $210.25 $314,878 - $360,368
1,714 Added 17.51%
11,504 $2.42 Million
Q1 2023

Apr 24, 2023

BUY
$191.89 - $259.92 $325,445 - $440,824
1,696 Added 20.95%
9,790 $1.98 Million
Q4 2022

Jan 25, 2023

BUY
$197.11 - $250.07 $197,701 - $250,820
1,003 Added 14.14%
8,094 $0
Q3 2022

Oct 25, 2022

BUY
$182.44 - $250.54 $1.05 Million - $1.44 Million
5,754 Added 430.37%
7,091 $1.4 Million
Q2 2022

Aug 04, 2022

BUY
$204.13 - $302.4 $122,273 - $181,137
599 Added 81.17%
1,337 $286,000
Q1 2022

Apr 19, 2022

BUY
$255.51 - $362.11 $68,987 - $97,769
270 Added 57.69%
738 $210,000
Q4 2021

Feb 01, 2022

BUY
$351.38 - $448.68 $36,543 - $46,662
104 Added 28.57%
468 $176,000
Q3 2021

Oct 15, 2021

BUY
$372.64 - $458.3 $49,561 - $60,953
133 Added 57.58%
364 $150,000
Q2 2021

Aug 06, 2021

BUY
$294.17 - $371.65 $21,474 - $27,130
73 Added 46.2%
231 $85,000
Q1 2021

May 07, 2021

SELL
$249.67 - $299.48 $23,968 - $28,750
-96 Reduced 37.8%
158 $46,000
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $47,952 - $54,565
216 Added 568.42%
254 $63,000
Q3 2020

Nov 09, 2020

SELL
$175.56 - $226.45 $9,480 - $12,228
-54 Reduced 58.7%
38 $9,000
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $2,501 - $2,873
-20 Reduced 17.86%
92 $12,000
Q2 2019

Aug 07, 2019

SELL
$123.4 - $148.55 $8,761 - $10,547
-71 Reduced 38.8%
112 $16,000
Q1 2019

May 14, 2019

SELL
$104.82 - $146.73 $5,345 - $7,483
-51 Reduced 21.79%
183 $27,000
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $5,359 - $6,998
51 Added 27.87%
234 $26,000
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $17,968 - $21,081
183 New
183 $20,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.63B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.